指南与共识口腔修复与种植牙周病

第一组ITI共识报告:骨尺寸与软组织增量对种植体疗效稳定性的作用

Group 1 ITI Consensus Report: The role of bone dimensions and soft tissue augmentation procedures on the stability of clinical, radiographic, and patient-reported outcomes of implant treatment.
指南 / 共识 · Clin Oral Implants Res · 2023-01-01

本共识报告基于两项系统综述,由第一工作组专家讨论形成共识。结论指出,愈合位点种植后牙槽嵴发生尺寸变化,颊侧骨壁厚度小于1.5 mm时临床和影像学结果较差;软组织增量可在中远期提供稳定的临床、影像学、美学及患者报告结局。

要点

  • 愈合位点种植后颊侧骨壁厚度可减少0.3至1.8 mm。
  • 种植后颊侧骨壁厚度小于1.5 mm的位点垂直骨吸收增加,结局较差。
  • 软组织增量可在1至5年内维持稳定的软组织边缘及美学效果。

核心结论

  • 愈合位点种植后牙槽嵴发生尺寸变化,种植后颊侧骨壁薄的位点临床和影像学结局较差。
  • 软组织增量可在中远期提供稳定的临床、影像学、美学及患者报告结局。

研究设计与样本

  • 第一工作组基于两项预先准备的系统综述,经结构化小组讨论直至全体专家达成共识,形成共识声明、临床推荐及未来研究建议。

主要发现

  • 愈合位点种植后颊侧骨壁厚度减少0.3至1.8 mm。
  • 种植后颊侧骨壁厚度小于1.5 mm的愈合位点垂直骨吸收增加,临床和影像学结局较差。
  • 颊侧开裂缺损种植体同期引导骨再生后,初期愈合期垂直骨吸收少于未增量的开裂缺损。
  • 健康单种植位点探测深度、出血和菌斑评分及邻面骨水平在1年评估后至5年保持稳定,无论是否行软组织增量。
  • 结缔组织移植增量的单种植位点1至5年软组织边缘稳定,软组织厚度和/或角化黏膜宽度稳定或增加;未增量位点长期更易出现软组织边缘根向迁移。

关键数值与推荐

  • 愈合位点种植后颊侧骨壁厚度小于1.5 mm与垂直骨吸收增加及较差的临床和影像学结局相关。
  • 软组织增量后美学和患者报告结局在1至5年保持稳定。

临床怎么用

  • 种植前评估颊侧骨壁厚度,对薄颊侧骨壁位点考虑引导骨再生以改善结局。
  • 对需要软组织表型改良或颊侧软组织开裂的单种植位点,可考虑结缔组织移植以维持软组织稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aims of Working Group 1 were to address the role (i) of the buccolingual bone dimensions after implant placement in healed alveolar ridge sites on the occurrence of biologic and aesthetic complications, and (ii) of soft tissue augmentation (STA) on the stability of clinical, radiographic, and patient-related outcomes of implant treatments. MATERIALS AND METHODS: Two systematic reviews were prepared in advance of the Consensus Conference and were discussed among the participants of Group 1. Consensus statements, clinical recommendations, recommendations for future research, and reflections on patient perspectives were based on structured group discussions until consensus was reached among the entire group of experts. The statements were then presented and accepted following further discussion and modifications as required by the plenary. RESULTS: Dimensional changes of the alveolar ridge occurred after implant placement in healed sites, and a reduction in buccal bone wall thickness (BBW) of 0.3 to 1.8 mm was observed. In healed sites with a BBW of <1.5 mm after implant placement, increased vertical bone loss, and less favorable clinical and radiographic outcomes were demonstrated. Implants with buccal dehiscence defects undergoing simultaneous guided bone regeneration, showed less vertical bone loss, and more favorable clinical and radiographic outcomes, compared to non-augmented dehiscence defects during initial healing. At healthy single implant sites, probing depths, bleeding and plaque scores, and interproximal bone levels evaluated at 1 year, remained stable for up to 5 years, with or without STA. When single implant sites were augmented with connective tissue grafts, either for soft tissue phenotype modification or buccal soft tissue dehiscence, stable levels of the soft tissue margin, and stable or even increased soft tissue thickness and/or width of keratinized mucosa could be observed from 1 to 5 years. In contrast, non-augmented sites were more prone to show apical migration of the soft tissue margin in the long-term. Favorable aesthetic and patient-reported outcomes after STA were documented to be stable from 1 to 5 years. CONCLUSIONS: It is concluded that dimensional changes of the alveolar ridge occur after implant placement in healed sites and that sites with a thin BBW after implant placement are prone to exhibit less favorable clinical and radiographic outcomes. In addition, it is concluded that STA can provide stable clinical, radiographic, aesthetic, and patient-reported outcomes in the medium and long-term.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Jensen SS, Aghaloo T, Jung RE, et al. Group 1 ITI Consensus Report: The role of bone dimensions and soft tissue augmentation procedures on the stability of clinical, radiographic, and patient-reported outcomes of implant treatment. Clin Oral Implants Res. 2023. PMID: 37750519. doi:10.1111/clr.14154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。